🟢 STAAR Surgical is trading 6% up in pre-market after Stifel’s Buy upgrade

STAAR Surgical is trading at $22.10, up 5.89% in pre-market; Stifel’s upgrade is a potential catalyst, though its role is unconfirmed.

• On September 28, Stifel upgraded STAAR Surgical to Buy from Hold and raised its price target to $31 from $28; its report was published early September 29.
• Stifel cited China’s EVO+ product mix shift and easier comparisons outside China as potential growth drivers. No trading-volume data was available in the provided price context.